Express Scripts Holding Company (NASDAQ:ESRX)‘s stock had its “buy” rating restated by equities research analysts at Jefferies Group LLC in a research report issued on Thursday, October 26th. Jefferies Group also issued estimates for Express Scripts Holding’s Q4 2017 earnings at $2.06 EPS, FY2017 earnings at $7.02 EPS and FY2018 earnings at $7.60 EPS.
A number of other research analysts have also recently commented on the company. ValuEngine cut Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Robert W. Baird restated a “hold” rating and set a $56.00 price target on shares of Express Scripts Holding in a research note on Friday, September 1st. Raymond James Financial, Inc. restated an “underperform” rating on shares of Express Scripts Holding in a research note on Monday, October 9th. Zacks Investment Research cut Express Scripts Holding from a “buy” rating to a “sell” rating in a research note on Tuesday, October 24th. Finally, Needham & Company LLC started coverage on Express Scripts Holding in a research note on Friday, July 21st. They set a “hold” rating on the stock. Seven analysts have rated the stock with a sell rating, ten have assigned a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Express Scripts Holding presently has an average rating of “Hold” and an average target price of $69.53.
Express Scripts Holding (NASDAQ:ESRX) opened at $60.25 on Thursday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. Express Scripts Holding has a 52 week low of $55.80 and a 52 week high of $77.50. The company has a market capitalization of $34,480.79, a price-to-earnings ratio of 8.90, a price-to-earnings-growth ratio of 0.90 and a beta of 0.88.
Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, hitting analysts’ consensus estimates of $1.90. Express Scripts Holding had a return on equity of 25.46% and a net margin of 3.64%. The company had revenue of $24.68 billion for the quarter, compared to analysts’ expectations of $25.68 billion. During the same period in the prior year, the firm earned $1.74 earnings per share. The firm’s revenue was down 2.9% compared to the same quarter last year. sell-side analysts predict that Express Scripts Holding will post 7.01 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: This report was originally reported by BBNS and is owned by of BBNS. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://baseballnewssource.com/markets/express-scripts-holding-company-esrx-given-buy-rating-at-jefferies-group-llc/1738608.html.
In other news, VP Everett Neville sold 1,163 shares of the stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the sale, the vice president now owns 18,232 shares in the company, valued at $1,120,903.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Timothy C. Wentworth bought 8,000 shares of the firm’s stock in a transaction dated Tuesday, October 31st. The shares were acquired at an average price of $61.13 per share, with a total value of $489,040.00. Following the purchase, the chief executive officer now directly owns 98,628 shares of the company’s stock, valued at approximately $6,029,129.64. The disclosure for this purchase can be found here. In the last ninety days, insiders have sold 6,284 shares of company stock worth $397,421. Corporate insiders own 0.68% of the company’s stock.
Several institutional investors and hedge funds have recently made changes to their positions in ESRX. Dodge & Cox boosted its stake in shares of Express Scripts Holding by 25.7% during the second quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock worth $2,310,275,000 after buying an additional 7,388,021 shares during the period. Pzena Investment Management LLC acquired a new stake in shares of Express Scripts Holding during the second quarter worth about $181,234,000. Renaissance Technologies LLC boosted its stake in shares of Express Scripts Holding by 9,353.3% during the first quarter. Renaissance Technologies LLC now owns 1,308,239 shares of the company’s stock worth $86,226,000 after buying an additional 1,294,400 shares during the period. Baupost Group LLC MA acquired a new stake in shares of Express Scripts Holding during the first quarter worth about $80,978,000. Finally, Northern Trust Corp boosted its stake in shares of Express Scripts Holding by 12.2% during the second quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock worth $706,629,000 after buying an additional 1,206,980 shares during the period. Institutional investors and hedge funds own 89.44% of the company’s stock.
Express Scripts Holding Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with our FREE daily email newsletter.